البحث عن طبيب

Gary L. Keeney, M.D.

  1. Pathologist
طلب موعد

المنشورات

  1. Dashti NK, Swanson AA, Patel V, Xing D, Feely M, Keeney GL, Gupta S, Schoolmeester JK. Leiomyosarcomas of the Visceral Adnexal and Uterine Ligaments and Adnexal Connective Tissue: Immunohistochemical, Molecular Genetic, and MDM2 Fluorescence In Situ Hybridization Analysis. Int J Gynecol Pathol. 2024 Jul 23 Epub 2024 July 23
    View PubMed
  2. Swanson AA, Michal M, Xing D, Dashti NK, Zidlik V, Cheek-Norgan EH, Keeney ME, Keeney GL, Sukov WR, Gupta S, Nucci MR, Schoolmeester JK. Malignant female genital tract smooth muscle tumors with adipocytic differentiation: A morphologic, immunohistochemical, MDM2 fluorescence in situ hybridization and molecular genetic study of 6 lipoleiomyosarcomas. Hum Pathol. 2024 Jan; 143:24-32 Epub 2023 Nov 23
    View PubMed
  3. Swanson AA, Michal M, Xing D, Zidlik V, Cheek-Norgan EH, Keeney ME, Keeney GL, Sukov WR, Gupta S, Nucci MR, Schoolmeester JK. Benign female genital tract smooth muscle tumors with adipocytic differentiation: A morphologic, immunohistochemical and MDM2 fluorescence in situ hybridization study of 44 conventional lipoleiomyomas and lipoleiomyoma variants. Hum Pathol. 2023 Dec; 142:51-61 Epub 2023 Nov 14
    View PubMed
  4. Bruce KH, Kilts TP, Lohman ME, Vidal NY, Fought AJ, McGree ME, Keeney GL, Baum CL, Brewer JD, Bakkum-Gamez JN, Cliby WA. Mohs surgery for female genital Paget's disease: a prospective observational trial. Am J Obstet Gynecol. 2023 Dec; 229(6):660.e1-660.e8. Epub 2023 Aug 24.
    View PubMed
  5. Sukov WR, Zhou J, Geiersbach KB, Keeney GL, Carter JM, Schoolmeester JK. Frequency of HER2 protein overexpression and HER2 gene amplification in endometrial clear cell carcinoma. Hum Pathol. 2023 Jul; 137:94-101 Epub 2023 Apr 23
    View PubMed
  6. Afshari M, Yasir S, Keeney GL, Jimenez RE, Garcia JJ, Tizhoosh HR. Single patch super-resolution of histopathology whole slide images: a comparative study. J Med Imaging (Bellingham). 2023 Jan; 10 (1):017501 Epub 2023 Jan 31
    View PubMed
  7. Zafar R, Schrader LJ, Cheville JC, Schoolmeester JK, Roden AC, Aubry MC, Yi ES, Raghunathan A, Herrera-Hernandez L, Thompson RH, Boorjian SA, Leibovich BC, Keeney GL, Jimenez RE, Gupta S. A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma. Hum Pathol. 2022 Oct; 128:31-47. Epub 2022 Jul 06.
    View PubMed
  8. Kumar A, Wang C, Sheedy SP, McCauley BM, Winham SJ, Ramus SJ, Anglesio MS, Kim B, Torres D, Keeney GL, Cliby WA, Goode EL. Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer. Gynecol Oncol. 2022 Sep; 166 (3):508-514 Epub 2022 Aug 02
    View PubMed
  9. Gill SE, Garzon S, Multinu F, Hokenstad AN, Casarin J, Cappuccio S, McGree ME, Weaver AL, Cliby WA, Keeney GL, Mariani A. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences. Int J Gynecol Cancer. 2021 Dec; 31(12):1541-1548. Epub 2021 Oct 27.
    View PubMed
  10. DeJong SR, Bakkum-Gamez JN, Clayton AC, Henry MR, Keeney GL, Zhang J, Kroneman TN, Laughlin-Tommaso SK, Ahlberg LJ, VanOosten AL, Weaver AL, Wentzensen N, Kerr SE. Tao brush endometrial cytology is a sensitive diagnostic tool for cancer and hyperplasia among women presenting to clinic with abnormal uterine bleeding. Cancer Med. 2021 Oct; 10 (20):7040-7047 Epub 2021 Sept 16
    View PubMed
  11. Carroll K, Mesman J, McLeod H, Boughey J, Keeney G, Habermann E. Seeing what works: identifying and enhancing successful interprofessional collaboration between pathology and surgery. J Interprof Care. 2021 Jul-Aug; 35(4):490-502. Epub 2018 Oct 18.
    View PubMed
  12. Dinoi G, Mariani A, Martinelli E, Ciucci A, Zannoni GF, Weaver AL, Keeney GL, Vasmatzis G, Anastasiadis PZ, Fanfani F, Scambia G, Gallo D. In search for biomarkers and potential drug targets for uterine serous endometrial cancer. J Cancer Res Clin Oncol. 2021 Jun; 147 (6):1647-1658 Epub 2021 Mar 23
    View PubMed
  13. Jeans EB, Breen WG, Mullikin TC, Looker BA, Mariani A, Keeney GL, Haddock MG, Petersen IA. Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer. Int J Gynecol Cancer. 2021 Jun; 31 (6):859-867 Epub 2021 Feb 09
    View PubMed
  14. Racz JM, Glasgow AE, Keeney GL, Degnim AC, Hieken TJ, Jakub JW, Cheville JC, Habermann EB, Boughey JC. Intraoperative Pathologic Margin Analysis and Re-Excision to Minimize Reoperation for Patients Undergoing Breast-Conserving Surgery. Ann Surg Oncol. 2020 Dec; 27 (13):5303-5311 Epub 2020 July 04
    View PubMed
  15. Talhouk A, George J, Wang C, Budden T, Tan TZ, Chiu DS, Kommoss S, Leong HS, Chen S, Intermaggio MP, Gilks B, Nazeran TM, Volchek M, Elatre W, Bentley RC, Senz J, Lum A, Chow V, Sudderuddin H, Mackenzie R, Leong SCY, Liu G, Johnson D, Chen B, Group A, Alsop J, Banerjee SN, Behrens S, Bodelon C, Brand AH, Brinton L, Carney ME, Chiew YE, Cushing-Haugen KL, Cybulski C, Ennis D, Fereday S, Fortner RT, Garcia-Donas J, Gentry-Maharaj A, Glasspool R, Goranova T, Greene CS, Haluska P, Harris HR, Hendley J, Hernandez BY, Herpel E, Jimenez-Linan M, Karpinskyj C, Kaufmann SH, Keeney GL, Kennedy CJ, Kobel M, Koziak JM, Larson MC, Lester J, Lewsley LA, Lissowska J, Lubinski J, Luk H, Macintyre G, Mahner S, McNeish IA, Menkiszak J, Nevins N, Osorio A, Oszurek O, Palacios J, Hinsley S, Pearce CL, Pike MC, Piskorz AM, Ray-Coquard I, Rhenius V, Rodriguez-Antona C, Sharma R, Sherman ME, De Silva D, Singh N, Sinn P, Slamon D, Song H, Steed H, Stronach EA, Thompson PJ, Toloczko A, Trabert B, Traficante N, Tseng CC, Widschwendter M, Wilkens LR, Winham SJ, Winterhoff B, Beeghly-Fadiel A, Benitez J, Berchuck A, Brenton JD, Brown R, Chang-Claude J, Chenevix-Trench G, deFazio A, Fasching PA, Garcia MJ, Gayther SA, Goodman MT, Gronwald J, Henderson MJ, Karlan BY, Kelemen LE, Menon U, Orsulic S, Pharoah PDP, Wentzensen N, Wu AH, Schildkraut JM, Rossing MA, Konecny GE, Huntsman DG, Huang RY, Goode EL, Ramus SJ, Doherty JA, Bowtell DD, Anglesio MS. Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE). Clin Cancer Res. 2020 Oct 15; 26 (20):5411-5423 Epub 2020 June 17
    View PubMed
  16. Martins FC, Couturier DL, Paterson A, Karnezis AN, Chow C, Nazeran TM, Odunsi A, Gentry-Maharaj A, Vrvilo A, Hein A, Talhouk A, Osorio A, Hartkopf AD, Brooks-Wilson A, DeFazio A, Fischer A, Hartmann A, Hernandez BY, McCauley BM, Karpinskyj C, de Sousa CB, Hogdall C, Tiezzi DG, Herpel E, Taran FA, Modugno F, Keeney G, Nelson G, Steed H, Song H, Luk H, Benitez J, Alsop J, Koziak JM, Lester J, Rothstein JH, de Andrade JM, Lundvall L, Paz-Ares L, Robles-Diaz L, Wilkens LR, Garcia MJ, Intermaggio MP, Alcaraz ML, Brett MA, Beckmann MW, Jimenez-Linan M, Anglesio M, Carney ME, Schneider M, Traficante N, Pejovic N, Singh N, Le N, Sinn P, Ghatage P, Erber R, Edwards R, Vierkant R, Ness RB, Leung S, Orsulic S, Brucker SY, Kaufmann SH, Fereday S, Gayther S, Winham SJ, Kommoss S, Pejovic T, Longacre TA, McGuire V, Rhenius V, Sieh W, Shvetsov YB, Whittemore AS, Staebler A, Karlan BY, Rodriguez-Antona C, Bowtell DD, Goode EL, Hogdall E, Candido Dos Reis FJ, Gronwald J, Chang-Claude J, Moysich KB, Kelemen LE, Cook LS, Goodman MT, Fasching PA, Crawford R, Deen S, Menon U, Huntsman DG, Kobel M, Ramus SJ, Pharoah PDP, Brenton JD. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium. Br J Cancer. 2020 Sep; 123 (5):793-802 Epub 2020 June 18
    View PubMed
  17. White J, Ball C, Young C, Bell D, Hall C, Healy T, Allen D, Phillips K, Millstein J, Budden T, Goode EL, Anglesio MS, Talhouk A, Intermaggio MP, Leong HS, Chen S, Elatre W, Gilks B, Nazeran T, Volchek M, Bentley RC, Wang C, Chiu DS, Kommoss S, Leung SCY, Senz J, Lum A, Chow V, Sudderuddin H, Mackenzie R, George J, Fereday S, Hendley J, Traficante N, Steed H, Koziak JM, Kobel M, McNeish IA, Goranova T, Ennis D, Macintyre G, Silva De Silva D, Ramon Y Cajal T, Garcia-Donas J, Hernando Polo S, Rodriguez GC, Cushing-Haugen KL, Harris HR, Greene CS, Zelaya RA, Behrens S, Fortner RT, Sinn P, Herpel E, Lester J, Lubinski J, Oszurek O, Toloczko A, Cybulski C, Menkiszak J, Pearce CL, Pike MC, Tseng C, Alsop J, Rhenius V, Song H, Jimenez-Linan M, Piskorz AM, Gentry-Maharaj A, Karpinskyj C, Widschwendter M, Singh N, Kennedy CJ, Sharma R, Harnett PR, Gao B, Johnatty SE, Sayer R, Boros J, Winham SJ, Keeney GL, Kaufmann SH, Larson MC, Larson MC, Luk H, Hernandez BY, Thompson PJ, Wilkens LR, Carney ME, Trabert B, Lissowska J, Brinton L, Sherman ME, Bodelon C, Hinsley S, Lewsley LA, Glasspool R, Banerjee SN, Stronach EA, Haluska P, Ray-Coquard I, Mahner S, Winterhoff B, Slamon D, Levine DA, Kelemen LE, Benitez J, Chang-Claude J, Gronwald J, Wu AH, Menon U, Goodman MT, Schildkraut JM, Wentzensen N, Brown R, Berchuck A, Chenevix-Trench G, deFazio A, Gayther SA, Garcia MJ, Henderson MJ, Rossing MA, Beeghly-Fadiel A, Fasching PA, Orsulic S, Karlan BY, Konecny GE, Huntsman DG, Bowtell DD, Brenton JD, Doherty JA, Pharoah PDP, Ramus SJ, AOCS Group. Prognostic gene expression signature for high-grade serous ovarian cancer. Ann Oncol. 2020 Sep; 31 (9):1240-1250 Epub 2020 May 28
    View PubMed
  18. Bogani G, Cappuccio S, Casarin J, Narasimhulu DMM, Cilby WA, Glaser GE, Weaver AL, McGree ME, Keeney GL, Weroha J, Petersen IA, Mariani A. Role of adjuvant therapy in stage IIIC2 endometrial cancer. Int J Gynecol Cancer. 2020 Aug; 30 (8):1169-1176 Epub 2020 July 09
    View PubMed
  19. Cheek EH, Fadra N, Jackson RA, Davila JI, Sukov WR, Uckerman MT, Clayton A, Keeney GL, Halling KC, Torres-Mora J, Schoolmeester JK. Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion. Hum Pathol. 2020 Mar; 97:29-39 Epub 2020 Jan 07
    View PubMed
  20. Meagher NS, Wang L, Rambau PF, Intermaggio MP, Huntsman DG, Wilkens LR, El-Bahrawy MA, Ness RB, Odunsi K, Steed H, Herpel E, Anglesio MS, Zhang B, Lambie N, Swerdlow AJ, Lubinski J, Vierkant RA, Goode EL, Menon U, Toloczko-Grabarek A, Oszurek O, Bilic S, Talhouk A, Garcia-Closas M, Wang Q, Tan A, Farrell R, Kennedy CJ, Jimenez-Linan M, Sundfeldt K, Etter JL, Menkiszak J, Goodman MT, Klonowski P, Leung Y, Winham SJ, Moysich KB, Behrens S, Kluz T, Edwards RP, Gronwald J, Modugno F, Hernandez BY, Chow C, Kelemen LE, Keeney GL, Carney ME, Natanzon Y, Robertson G, Sharma R, Gayther SA, Alsop J, Luk H, Karpinskyj C, Campbell I, Sinn P, Gentry-Maharaj A, Coulson P, Chang-Claude J, Shah M, Widschwendter M, Tang K, Schoemaker MJ, Koziak JM, Cook LS, Brenton JD, Daley F, Kristjansdottir B, Mateoiu C, Larson MC, Harnett PR, Jung A, deFazio A, Gorringe KL, Pharoah PDP, Minoo P, Stewart C, Bathe OF, Gui X, Cohen P, Ramus SJ, Kobel M. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. Mod Pathol. 2019 Dec; 32 (12):1834-1846 Epub 2019 June 25
    View PubMed
  21. Multinu F, Ducie JA, Eriksson AGZ, Schlappe BA, Cliby WA, Glaser GE, Grassi T, Keeney GL, Weaver AL, Abu-Rustum NR, Leitao MM Jr, Mariani A. Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm. Gynecol Oncol. 2019 Nov; 155 (2):177-185 Epub 2019 Oct 08
    View PubMed
  22. Tortorella L, Casarin J, Multinu F, Cappuccio S, McGree ME, Weaver AL, Langstraat CL, Keeney GL, Kumar A, Melis GB, Angioni S, Scambia G, Mariani A, Glaser GE. Sentinel lymph node biopsy with cervical injection of indocyanine green in apparent early-stage endometrial cancer: predictors of unsuccessful mapping. Gynecol Oncol. 2019 Oct; 155(1):34-38. Epub 2019 Aug 08.
    View PubMed
  23. Multinu F, Casarin J, Cappuccio S, Keeney GL, Glaser GE, Cliby WA, Weaver AL, McGree ME, Angioni S, Faa G, Leitao MM Jr, Abu-Rustum NR, Mariani A. Ultrastaging of negative pelvic lymph nodes to decrease the true prevalence of isolated paraaortic dissemination in endometrial cancer. Gynecol Oncol. 2019 Jul; 154(1):60-64. Epub 2019 May 22.
    View PubMed
  24. Jahanseir K, Xing D, Greipp PT, Sukov WR, Keeney GL, Howitt BE, Schoolmeester JK. PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants. Int J Gynecol Pathol. 2018 Nov; 37 (6):537-546
    View PubMed
  25. Hale VL, Jeraldo P, Chen J, Mundy M, Chen J, Yao J, Priya S, Keeney G, Lyke K, Ridlon J, White BA, French AJ, Thibodeau SN, Diener C, Resendis-Antonio O, Gransee J, Dutta T, Petterson XM, Sung J, Blekhman R, Boardman L, Larson D, Nelson H, Chia N. Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers. Genome Med. 2018 Oct 31; 10 (1):78
    View PubMed
  26. Hale VL, Jeraldo P, Mundy M, Yao J, Keeney G, Scott N, Cheek EH, Davidson J, Greene M, Martinez C, Lehman J, Pettry C, Reed E, Lyke K, White BA, Diener C, Resendis-Antonio O, Gransee J, Dutta T, Petterson XM, Boardman L, Larson D, Nelson H, Chia N. Synthesis of multi-omic data and community metabolic models reveals insights into the role of hydrogen sulfide in colon cancer. Methods. 2018 Oct 1; 149:59-68 Epub 2018 Apr 26
    View PubMed
  27. Schoolmeester JK, Xing D, Keeney GL, Sukov WR. Genital Rhabdomyoma of the Lower Female Genital Tract: A Study of 12 Cases With Molecular Cytogenetic Findings. Int J Gynecol Pathol. 2018 Jul; 37 (4):349-355
    View PubMed
  28. Tortorella L, Langstraat CL, Weaver AL, McGree ME, Bakkum-Gamez JN, Dowdy SC, Cliby WA, Keeney GL, Sherman ME, Weroha SJ, Mariani A, Podratz KC. Uterine serous carcinoma: Reassessing effectiveness of platinum-based adjuvant therapy. Gynecol Oncol. 2018 May; 149(2):291-296. Epub 2018 Mar 14.
    View PubMed
  29. Murphy BL, Boughey JC, Keeney MG, Glasgow AE, Racz JM, Keeney GL, Habermann EB. Factors Associated With Positive Margins in Women Undergoing Breast Conservation Surgery. Mayo Clin Proc. 2018 Apr; 93 (4):429-435 Epub 2018 Feb 10
    View PubMed
  30. Ducie JA, Eriksson AGZ, Ali N, McGree ME, Weaver AL, Bogani G, Cliby WA, Dowdy SC, Bakkum-Gamez JN, Soslow RA, Keeney GL, Abu-Rustum NR, Mariani A, Leitao MM Jr. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease. Gynecol Oncol. 2017 Dec; 147(3):541-548. Epub 2017 Sep 29.
    View PubMed
  31. Schoolmeester JK, Moyer AM, Goodenberger ML, Keeney GL, Carter JM, Bakkum-Gamez JN. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2. Hum Pathol. 2017 Dec; 70:14-26 Epub 2017 July 12
    View PubMed
  32. Gill SE, Zhang Q, Keeney GL, Cliby WA, Weroha SJ. Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIR. Oncotarget. 2017 Oct 17; 8 (49):85214-85223 Epub 2017 July 27
    View PubMed
  33. Murphy BL, Glasgow AE, Keeney GL, Habermann EB, Boughey JC. Selective Use of Sentinel Lymph Node Surgery in Patients Undergoing Prophylactic Mastectomy Using Intraoperative Pathology. Ann Surg Oncol. 2017 Oct; 24 (10):3032-3037 Epub 2017 Aug 01
    View PubMed
  34. Olsen DL, Keeney GL, Chen B, Visscher DW, Carter JM. Breast implant capsule-associated squamous cell carcinoma: a report of 2 cases. Hum Pathol. 2017 Sep; 67:94-100 Epub 2017 July 22
    View PubMed
  35. Wang C, Armasu SM, Kalli KR, Maurer MJ, Heinzen EP, Keeney GL, Cliby WA, Oberg AL, Kaufmann SH, Goode EL. Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes. Clin Cancer Res. 2017 Aug 1; 23 (15):4077-4085 Epub 2017 Mar 09
    View PubMed
  36. Schoolmeester JK, Carlson J, Keeney GL, Fritchie KJ, Oliva E, Young RH, Nucci MR. Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics. Am J Surg Pathol. 2017 May; 41 (5):622-632
    View PubMed
  37. Mehner C, Oberg AL, Goergen KM, Kalli KR, Maurer MJ, Nassar A, Goode EL, Keeney GL, Jatoi A, Radisky DC, Radisky ES. EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review. Genes Cancer. 2017 May; 8 (5-6):589-599
    View PubMed
  38. Richards EG, El-Nashar SA, Schoolmeester JK, Keeney GL, Mariani A, Hopkins MR, Dowdy SC, Daftary GS, Famuyide AO. Abnormal Uterine Bleeding Is Associated With Increased BMP7 Expression in Human Endometrium. Reprod Sci. 2017 May; 24(5):671-681. Epub 2016 Oct 07.
    View PubMed
  39. Fahy AS, Grotz TE, Keeney GL, Glasgow AE, Habermann EB, Erickson L, Hieken TJ, Jakub JW. Frozen section analysis of SLNs in trunk and extremity melanoma has a high false negative rate but can spare some patients a second operation. J Surg Oncol. 2016 Dec; 114: (7)879-883.
    View PubMed
  40. Walther-Antonio MR, Chen J, Multinu F, Hokenstad A, Distad TJ, Cheek EH, Keeney GL, Creedon DJ, Nelson H, Mariani A, Chia N. Potential contribution of the uterine microbiome in the development of endometrial cancer. Genome Med. 2016 Nov 25; 8 (1):122
    View PubMed
  41. Murphy BL, Boughey JC, Degnim AC, Hieken TJ, Harmsen WS, Keeney GL, Jakub JW. A Picture is Worth a Thousand Words: Intraoperative Photography as a Quality Metric for Axillary Dissection. Ann Surg Oncol. 2016 Oct; 23 (11):3494-3500 Epub 2016 May 19
    View PubMed
  42. Uccella S, Morris JM, Multinu F, Cliby WA, Podratz KC, Gostout BS, Dowdy SC, Ghezzi F, Makdisi PB, Keeney GL, Link MJ, Mariani A. Primary brain metastases of endometrial cancer: A report of 18 cases and review of the literature. Gynecol Oncol. 2016 Jul; 142 (1):70-75 Epub 2016 Apr 26
    View PubMed
  43. Wang C, Winterhoff BJ, Kalli KR, Block MS, Armasu SM, Larson MC, Chen HW, Keeney GL, Hartmann LC, Shridhar V, Konecny GE, Goode EL, Fridley BL. Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer. Br J Cancer. 2016 Jun 14; 114 (12):1412-20 Epub 2016 June 02
    View PubMed
  44. Winterhoff B, Hamidi H, Wang C, Kalli KR, Fridley BL, Dering J, Chen HW, Cliby WA, Wang HJ, Dowdy S, Gostout BS, Keeney GL, Goode EL, Konecny GE. Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures. Gynecol Oncol. 2016 Apr; 141 (1):95-100
    View PubMed
  45. Boughey JC, Keeney GL, Radensky P, Song CP, Habermann EB. Economic Implications of Widespread Expansion of Frozen Section Margin Analysis to Guide Surgical Resection in Women With Breast Cancer Undergoing Breast-Conserving Surgery. J Oncol Pract. 2016 Apr; 12: (4)e413-22.
    View PubMed
  46. Mehner C, Oberg AL, Kalli KR, Nassar A, Hockla A, Pendlebury D, Cichon MA, Goergen KM, Maurer MJ, Goode EL, Keeney GL, Jatoi A, Sahin-Toth M, Copland JA, Radisky DC, Radisky ES. Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers. Oncotarget. 2015 Nov 3; 6 (34):35737-54
    View PubMed
  47. Schoolmeester JK, Sciallis AP, Greipp PT, Hodge JC, Dal Cin P, Keeney GL, Nucci MR. Analysis of MDM2 Amplification in 43 Endometrial Stromal Tumors: A Potential Diagnostic Pitfall. Int J Gynecol Pathol. 2015 Nov; 34 (6):576-83
    View PubMed
  48. Schoolmeester JK, Greipp PT, Keeney GL, Soslow RA. Ovarian Hemangiomas Do Not Harbor EWSR1 Rearrangements: Clinicopathologic Characterization of 10 Cases. Int J Gynecol Pathol. 2015 Sep; 34 (5):437-44
    View PubMed
  49. AlHilli MM, Bakkum-Gamez JN, Mariani A, Weaver AL, McGree ME, Keeney GL, Jatoi A, Dowdy SC, Podratz KC. Risk-adjusted outcomes in elderly endometrial cancer patients: implications of the contrasting impact of age on progression-free and cause-specific survival. Gynecol Oncol. 2015 Jul; 138(1):133-40. Epub 2015 Apr 17.
    View PubMed
  50. Wahner Hendrickson AE, Hawthorne KM, Goode EL, Kalli KR, Goergen KM, Bakkum-Gamez JN, Cliby WA, Keeney GL, Visscher DW, Tarabishy Y, Oberg AL, Hartmann LC, Maurer MJ. Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic. Gynecol Oncol. 2015 Apr; 137 (1):77-85 Epub 2015 Jan 22
    View PubMed
  51. Galanis E, Atherton PJ, Maurer MJ, Knutson KL, Dowdy SC, Cliby WA, Haluska P Jr, Long HJ, Oberg A, Aderca I, Block MS, Bakkum-Gamez J, Federspiel MJ, Russell SJ, Kalli KR, Keeney G, Peng KW, Hartmann LC. Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer. Cancer Res. 2015 Jan 1; 75 (1):22-30 Epub 2014 Nov 14
    View PubMed
  52. Ayeni TA, AlHilli MM, Bakkum-Gamez JN, Mariani A, McGree ME, Weaver AL, Cliby WA, Keeney GL, Podratz KC, Dowdy SC. Distribution and volume of extrauterine disease in uterine serous carcinoma: is minimally invasive surgery a suitable approach? Int J Gynecol Cancer. 2015 Jan; 25(1):87-91.
    View PubMed
  53. Kobel M, Madore J, Ramus SJ, Clarke BA, Pharoah PD, Deen S, Bowtell DD, Odunsi K, Menon U, Morrison C, Lele S, Bshara W, Sucheston L, Beckmann MW, Hein A, Thiel FC, Hartmann A, Wachter DL, Anglesio MS, Hogdall E, Jensen A, Hogdall C, Kalli KR, Fridley BL, Keeney GL, Fogarty ZC, Vierkant RA, Liu S, Cho S, Nelson G, Ghatage P, Gentry-Maharaj A, Gayther SA, Benjamin E, Widschwendter M, Intermaggio MP, Rosen B, Bernardini MQ, Mackay H, Oza A, Shaw P, Jimenez-Linan M, Driver KE, Alsop J, Mack M, Koziak JM, Steed H, Ewanowich C, DeFazio A, Chenevix-Trench G, Fereday S, Gao B, Johnatty SE, George J, Galletta L, Goode EL, Kjaer SK, Huntsman DG, Fasching PA, Moysich KB, Brenton JD, Kelemen LE, AOCS Study Group. Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study. Br J Cancer. 2014 Dec 9; 111 (12):2297-307 Epub 2014 Oct 30
    View PubMed
  54. Zheng Y, Tabbaa ZM, Khan Z, Schoolmeester JK, El-Nashar S, Famuyide A, Keeney GL, Daftary GS. Epigenetic regulation of uterine biology by transcription factor KLF11 via posttranslational histone deacetylation of cytochrome p450 metabolic enzymes. Endocrinology. 2014 Nov; 155 (11):4507-20 Epub 2014 July 30
    View PubMed
  55. Konecny GE, Wang C, Hamidi H, Winterhoff B, Kalli KR, Dering J, Ginther C, Chen HW, Dowdy S, Cliby W, Gostout B, Podratz KC, Keeney G, Wang HJ, Hartmann LC, Slamon DJ, Goode EL. Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer. J Natl Cancer Inst. 2014 Oct; 106 (10) Epub 2014 Sept 30
    View PubMed
  56. Sciallis AP, Bedroske PP, Schoolmeester JK, Sukov WR, Keeney GL, Hodge JC, Bell DA. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features. Am J Surg Pathol. 2014 Sep; 38(9):1161-72.
    View PubMed
  57. Boughey JC, Hieken TJ, Jakub JW, Degnim AC, Grant CS, Farley DR, Thomsen KM, Osborn JB, Keeney GL, Habermann EB. Impact of analysis of frozen-section margin on reoperation rates in women undergoing lumpectomy for breast cancer: evaluation of the National Surgical Quality Improvement Program data. Surgery. 2014 Jul; 156 (1):190-7 Epub 2014 Mar 18
    View PubMed
  58. AlHilli MM, Mariani A, Bakkum-Gamez JN, Dowdy SC, Weaver AL, Peethambaram PP, Keeney GL, Cliby WA, Podratz KC. Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer. Gynecol Oncol. 2014 Jun; 133 (3):485-93 Epub 2014 Mar 29
    View PubMed
  59. Wysokinska EM, Keeney G. Breast cancer occurring in the chest wall: rare presentation of ectopic milk line breast cancer. J Clin Oncol. 2014 Apr 1; 32 (10):e35-6 Epub 2014 Jan 21
    View PubMed
  60. Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Martin JR, Keeney GL, Jatoi A, Gostout BS, Podratz KC. Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy. Gynecol Oncol. 2014 Mar; 132(3):578-84. Epub 2014 Jan 14.
    View PubMed
  61. Kumar S, Podratz KC, Bakkum-Gamez JN, Dowdy SC, Weaver AL, McGree ME, Cliby WA, Keeney GL, Thomas G, Mariani A. Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer. Gynecol Oncol. 2014 Jan; 132 (1):38-43 Epub 2013 Oct 09
    View PubMed
  62. Glazebrook KN, Keeney GL, Rock MG. Ultrasound of primary aneurysmal bone cyst. Case Rep Radiol. 2014; 2014:101069 Epub 2014 Jan 23
    View PubMed
  63. AlHilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, Keeney GL, Cliby WA, Mariani A. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer. Gynecol Oncol. 2013 Oct; 131 (1):103-8 Epub 2013 July 09
    View PubMed
  64. Kobel M, Kalloger SE, Lee S, Duggan MA, Kelemen LE, Prentice L, Kalli KR, Fridley BL, Visscher DW, Keeney GL, Vierkant RA, Cunningham JM, Chow C, Ness RB, Moysich K, Edwards R, Modugno F, Bunker C, Wozniak EL, Benjamin E, Gayther SA, Gentry-Maharaj A, Menon U, Gilks CB, Huntsman DG, Ramus SJ, Goode EL, Ovarian Tumor Tissue Analysis consortium. Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium. Cancer Epidemiol Biomarkers Prev. 2013 Oct; 22 (10):1677-86 Epub 2013 July 23
    View PubMed
  65. Kumar S, Mariani A, Bakkum-Gamez JN, Weaver AL, McGree ME, Keeney GL, Cliby WA, Podratz KC, Dowdy SC. Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer. Gynecol Oncol. 2013 Sep; 130 (3):441-5 Epub 2013 June 05
    View PubMed
  66. Uccella S, Morris JM, Bakkum-Gamez JN, Keeney GL, Podratz KC, Mariani A. Bone metastases in endometrial cancer: report on 19 patients and review of the medical literature. Gynecol Oncol. 2013 Sep; 130 (3):474-82 Epub 2013 May 15
    View PubMed
  67. Sieh W, Kobel M, Longacre TA, Bowtell DD, deFazio A, Goodman MT, Hogdall E, Deen S, Wentzensen N, Moysich KB, Brenton JD, Clarke BA, Menon U, Gilks CB, Kim A, Madore J, Fereday S, George J, Galletta L, Lurie G, Wilkens LR, Carney ME, Thompson PJ, Matsuno RK, Kjaer SK, Jensen A, Hogdall C, Kalli KR, Fridley BL, Keeney GL, Vierkant RA, Cunningham JM, Brinton LA, Yang HP, Sherman ME, Garcia-Closas M, Lissowska J, Odunsi K, Morrison C, Lele S, Bshara W, Sucheston L, Jimenez-Linan M, Driver K, Alsop J, Mack M, McGuire V, Rothstein JH, Rosen BP, Bernardini MQ, Mackay H, Oza A, Wozniak EL, Benjamin E, Gentry-Maharaj A, Gayther SA, Tinker AV, Prentice LM, Chow C, Anglesio MS, Johnatty SE, Chenevix-Trench G, Whittemore AS, Pharoah PD, Goode EL, Huntsman DG, Ramus SJ. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol. 2013 Aug; 14 (9):853-62 Epub 2013 July 09
    View PubMed
  68. Ayeni TA, Bakkum-Gamez JN, Mariani A, McGree ME, Weaver AL, Haddock MG, Keeney GL, Long HJ 3rd, Dowdy SC, Podratz KC. Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas. Gynecol Oncol. 2013 Jun; 129(3):478-85. Epub 2013 Mar 25.
    View PubMed
  69. AlHilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, Kumar S, Keeney GL, Cliby WA, Mariani A. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol. 2013 Feb; 128(2):294-9. Epub 2012 Oct 17.
    View PubMed
  70. Alhilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, Kumar S, Keeney GL, Cliby WA, Mariani A. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Obstet Gynecol Surv. 2013; 68(3):199-200.
  71. Daftary GS, Zheng Y, Tabbaa ZM, Schoolmeester JK, Gada RP, Grzenda AL, Mathison AJ, Keeney GL, Lomberk GA, Urrutia R. A novel role of the Sp/KLF transcription factor KLF11 in arresting progression of endometriosis. PLoS One. 2013; 8 (3):e60165 Epub 2013 Mar 28
    View PubMed
  72. Ayeni TA, Bakkum-Gamez JN, Mariani A, McGree ME, Weaver AL, AlHilli MM, Martin JR, Keeney GL, Dowdy SC, Podratz KC. Impact of tubal ligation on routes of dissemination and overall survival in uterine serous carcinoma. Gynecol Oncol. 2013 Jan; 128(1):71-76. Epub 2012 Nov 02.
    View PubMed
  73. Kumar S, Medeiros F, Dowdy SC, Keeney GL, Bakkum-Gamez JN, Podratz KC, Cliby WA, Mariani A. A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. Gynecol Oncol. 2012 Dec; 127 (3):525-31 Epub 2012 Aug 29
    View PubMed
  74. Schoolmeester JK, Keeney GL. Collision tumor of the ovary: adult granulosa cell tumor and endometrioid carcinoma. Int J Gynecol Pathol. 2012 Nov; 31(6):538-40.
    View PubMed
  75. Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR, Keeney GL, Mariani A, Podratz KC. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol. 2012 Oct; 127(1):5-10. Epub 2012 Jul 03.
    View PubMed
  76. Bakkum-Gamez JN, Kalogera E, Keeney GL, Mariani A, Podratz KC, Dowdy SC. Conservative Management of Atypical Hyperplasia and Grade I Endometrial Carcinoma in Women of Child-Bearing Age Journal of Gynecologic Surgery. 2012.
  77. Lima JF, Jin L, de Araujo AR, Erikson-Johnson MR, Oliveira AM, Sebo TJ, Keeney GL, Medeiros F. FOXL2 mutations in granulosa cell tumors occurring in males. Arch Pathol Lab Med. 2012 Jul; 136 (7):825-8
    View PubMed
  78. Fuehrer NE, Keeney GL, Ketterling RP, Knudson RA, Bell DA. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract. Arch Pathol Lab Med. 2012 Jun; 136 (6):623-6
    View PubMed
  79. AlHilli MM, Dowdy SC, Weaver AL, St Sauver JL, Keeney GL, Mariani A, Podratz KC, Bakkum-Gamez JN. Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study. Gynecol Oncol. 2012 Apr; 125 (1):109-13 Epub 2011 Dec 28
    View PubMed
  80. Bakkum-Gamez JN, Kalogera E, Keeney GL, Mariani A, Podratz KC, Dowdy SC. Conservative management of atypical hyperplasia and grade i endometrial carcinoma: Review of the literature and presentation of a series. J Gynecol Surg. 2012; 28(4):262-9.
  81. Ozsan N, Bedke BJ, Law ME, Inwards DJ, Ketterling RP, Knudson RA, Keeney GL, Dogan A, Feldman AL. Clinicopathologic and genetic characterization of follicular lymphomas presenting in the ovary reveals 2 distinct subgroups. Am J Surg Pathol. 2011 Nov; 35(11):1691-9.
    View PubMed
  82. Osborn JB, Keeney GL, Jakub JW, Degnim AC, Boughey JC. Cost-effectiveness analysis of routine frozen-section analysis of breast margins compared with reoperation for positive margins. Ann Surg Oncol. 2011 Oct; 18(11):3204-9. Epub 2011 Aug 23.
    View PubMed
  83. Goode EL, Chenevix-Trench G, Hartmann LC, Fridley BL, Kalli KR, Vierkant RA, Larson MC, White KL, Keeney GL, Oberg TN, Cunningham JM, Beesley J, Johnatty SE, Chen X, Goodman KE, Armasu SM, Rider DN, Sicotte H, Schmidt MM, Elliott EA, Høgdall E, Kjær SK, Fasching PA, Ekici AB, Lambrechts D, Despierre E, Høgdall C, Lundvall L, Karlan BY, Gross J, Brown R, Chien J, Duggan DJ, Tsai YY, Phelan CM, Kelemen LE, Peethambaram PP, Schildkraut JM, Shridhar V, Sutphen R, Couch FJ, Sellers TA, Ovarian Cancer Association Consortium. Assessment of hepatocyte growth factor in ovarian cancer mortality. Cancer Epidemiol Biomarkers Prev. 2011 Aug; 20(8):1638-48. Epub 2011 Jul 01.
    View PubMed
  84. Weroha SJ, Oberg AL, Ziegler KL, Dakhilm SR, Rowland KM, Hartmann LC, Moore DF, Keeney GL, Peethambaram PP, Haluska P. Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma. Gynecol Oncol. 2011 Jul; 122(1):116-20. Epub 2011 Apr 22.
    View PubMed
  85. Uccella S, Cha SS, Melton LJ 3rd, Bergstralh EJ, Boardman LA, Keeney GL, Podratz KC, Ciancio FF, Mariani A. Risk factors for developing multiple malignancies in patients with endometrial cancer. Int J Gynecol Cancer. 2011 Jul; 21 (5):896-901
    View PubMed
  86. Peethambaram P, Fridley BL, Vierkant RA, Larson MC, Kalli KR, Elliott EA, Oberg AL, White KL, Rider DN, Keeney GL, Cunningham JM, Hartmann LC, Goode EL. Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome. Int J Mol Epidemiol Genet. 2011; 2(2):185-95. Epub 2011 May 02.
    View PubMed
  87. Reynolds EA, Tierney K, Keeney GL, Felix JC, Weaver AL, Roman LD, Cliby WA. Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type. Obstet Gynecol. 2010 Nov; 116(5):1150-7.
    View PubMed
  88. Sukov WR, Ketterling RP, Wei S, Monaghan K, Blunden P, Mazzara P, Raghavan R, Oliviera AM, Wiktor AE, Keeney GL, Van Dyke. Nearly identical near-haploid karyotype in a peritoneal mesothelioma and a retroperitoneal malignant peripheral nerve sheath tumor. Cancer Genet Cytogenet. 2010 Oct 15; 202(2):123-8.
    View PubMed
  89. Bakkum-Gamez JN, Richardson DL, Seamon LG, Aletti GD, Powless CA, Keeney GL, O'Malley DM, Cliby WA. Is there a high-risk subgroup of stage I epithelial ovarian cancer that is most likely to benefit from 6 versus 3 cycles of adjuvant chemotherapy? Int J Gynecol Cancer. 2010 Oct; 20 (7):1125-31
    View PubMed
  90. Litzow MR, Peethambaram PP, Safgren SL, Keeney GL, Ansell SM, Dispenzieri A, Elliott MA, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, Micallef IN, Porrata LF, Lingle WL, Hartmann LC, Frost MH, Barrette BA, Long HJ, Suman VJ, Reid JM, Ames MM, Kaufmann SH. Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma. Bone Marrow Transplant. 2010 Mar; 45 (3):490-7 Epub 2009 Aug 03
    View PubMed
  91. Gonzalez Bosquet, Terstriep SA, Cliby WA, Brown-Jones M, Kaur JS, Podratz KC, Keeney GL. The impact of multi-modal therapy on survival for uterine carcinosarcomas. Gynecol Oncol. 2010 Mar; 116(3):419-23. Epub 2009 Nov 05.
    View PubMed
  92. Goode EL, Maurer MJ, Sellers TA, Phelan CM, Kalli KR, Fridley BL, Vierkant RA, Armasu SM, White KL, Keeney GL, Cliby WA, Rider DN, Kelemen LE, Jones MB, Peethambaram PP, Lancaster JM, Olson JE, Schildkraut JM, Cunningham JM, Hartmann LC. Inherited determinants of ovarian cancer survival. Clin Cancer Res. 2010 Feb 1; 16 (3):995-1007 Epub 2010 Jan 26
    View PubMed
  93. Galanis E, Hartmann LC, Cliby WA, Long HJ, Peethambaram PP, Barrette BA, Kaur JS, Haluska PJ Jr, Aderca I, Zollman PJ, Sloan JA, Keeney G, Atherton PJ, Podratz KC, Dowdy SC, Stanhope CR, Wilson TO, Federspiel MJ, Peng KW, Russell SJ. Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. Cancer Res. 2010 Feb 1; 70 (3):875-82 Epub 2010 Jan 26
    View PubMed
  94. Mariani A, Cha SS, Bergstralh EJ, Boardman LA, Dowdy SC, Keeney GL, Podratz KC, Melton LJ 3rd. Referral and ascertainment bias in patients with synchronous and metachronous endometrial malignancy. Eur J Gynaecol Oncol. 2010; 31 (1):5-9
    View PubMed
  95. Thomas MB, Keeney GL, Podratz KC, Dowdy SC. Endometrial stromal sarcoma: treatment and patterns of recurrence. Int J Gynecol Cancer. 2009 Feb; 19 (2):253-6
    View PubMed
  96. Konecny GE, Santos L, Winterhoff B, Hatmal M, Keeney GL, Mariani A, Jones M, Neuper C, Thomas B, Muderspach L, Riehle D, Wang HJ, Dowdy S, Podratz KC, Press MF. HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer. Br J Cancer. 2009 Jan 13; 100 (1):89-95 Epub 2008 Dec 16
    View PubMed
  97. Bakkum-Gamez JN, Richardson DL, Seamon LG, Aletti GD, Powless CA, Keeney GL, O'Malley DM, Cliby WA. Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer. Obstet Gynecol. 2009 Jan; 113 (1):11-17
    View PubMed
  98. Brown Jones M, Neuper C, Clayton A, Mariani A, Konecny G, Thomas MB, Keeney G, Hartmann L, Podratz KC. Rationale for folate receptor alpha targeted therapy in "high risk" endometrial carcinomas. Int J Cancer. 2008 Oct 1; 123 (7):1699-703
    View PubMed
  99. Keeney G, Leslie K. Preparing fresh tissues for the microscope. JAMA. 2008 Sep 3; 300: (9)1074-6.
    View PubMed
  100. Kipp BR, Medeiros F, Campion MB, Distad TJ, Peterson LM, Keeney GL, Halling KC, Clayton AC. Direct uterine sampling with the Tao brush sampler using a liquid-based preparation method for the detection of endometrial cancer and atypical hyperplasia: a feasibility study. Cancer. 2008 Aug 25; 114(4):228-35.
    View PubMed
  101. Konecny GE, Agarwal R, Keeney GA, Winterhoff B, Jones MB, Mariani A, Riehle D, Neuper C, Dowdy SC, Wang HJ, Morin PJ, Podratz KC. Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer. Gynecol Oncol. 2008 May; 109 (2):263-9 Epub 2008 Mar 07
    View PubMed
  102. Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol. 2008 Apr; 21 (4):455-63 Epub 2008 Jan 25
    View PubMed
  103. Kalli KR, Oberg AL, Keeney GL, Christianson TJ, Low PS, Knutson KL, Hartmann LC. Folate receptor alpha as a tumor target in epithelial ovarian cancer. Gynecol Oncol. 2008 Mar; 108 (3):619-26 Epub 2008 Jan 28
    View PubMed
  104. Bakkum-Gamez JN, Aletti G, Lewis KA, Keeney GL, Thomas BM, Navarro-Teulon I, Cliby WA. Mullerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers. Gynecol Oncol. 2008 Jan; 108(1):141-8. Epub 2007 Nov 07.
    View PubMed
  105. Chien JR, Aletti G, Bell DA, Keeney GL, Shridhar V, Hartmann LC. Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer. J Cell Biochem. 2007 Dec 1; 102(5):1117-29.
    View PubMed
  106. Dowdy SC, Mariani A, Bakkum JN, Cliby WA, Keeney GL, Podratz KC. Treatment of pulmonary recurrences in patients with endometrial cancer. Gynecol Oncol. 2007 Nov; 107(2):242-7. Epub 2007 Sep 17.
    View PubMed
  107. Giuntoli RL 2nd, Gostout BS, DiMarco CS, Metzinger DS, Keeney GL. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior. J Reprod Med. 2007 Nov; 52(11):1001-10.
    View PubMed
  108. Thomas MB, Mariani A, Cliby WA, Keeney GL, Podratz KC, Dowdy SC. Role of cytoreduction in stage III and IV uterine papillary serous carcinoma. Gynecol Oncol. 2007 Nov; 107 (2):190-3 Epub 2007 Sept 06
    View PubMed
  109. Medeiros F, Erickson-Johnson MR, Keeney GL, Clayton AC, Nascimento AG, Wang X, Oliveira AM. Frequency and characterization of HMGA2 and HMGA1 rearrangements in mesenchymal tumors of the lower genital tract. Genes Chromosomes Cancer. 2007 Nov; 46(11):981-90.
    View PubMed
  110. Hartmann LC, Keeney GL, Lingle WL, Christianson TJ, Varghese B, Hillman D, Oberg AL, Low PS. Folate receptor overexpression is associated with poor outcome in breast cancer. Int J Cancer. 2007 Sep 1; 121: (5)938-42.
    View PubMed
  111. Levy MJ, Topazian M, Keeney G, Clain JE, Gleeson F, Rajan E, Wang KK, Wiersema MJ, Farnell M, Chari S. Preoperative diagnosis of extrapancreatic neural invasion in pancreatic cancer. Clin Gastroenterol Hepatol. 2006 Dec; 4: (12)1479-82.
    View PubMed
  112. Levy M, Rajan E, Keeney G, Fletcher JG, Topazian M. Neural ganglia visualized by endoscopic ultrasound. Am J Gastroenterol. 2006 Aug; 101: (8)1787-91.
    View PubMed
  113. Chien J, Aletti G, Baldi A, Catalano V, Muretto P, Keeney GL, Kalli KR, Staub J, Ehrmann M, Cliby WA, Lee YK, Bible KC, Hartmann LC, Kaufmann SH, Shridhar V. Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity. J Clin Invest. 2006 Jul; 116 (7):1994-2004 Epub 2006 June 08
    View PubMed
  114. Mariani A, Dowdy SC, Cliby WA, Haddock MG, Keeney GL, Lesnick TG, Podratz KC. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol. 2006 May; 101 (2):200-8 Epub 2006 Feb 28
    View PubMed
  115. Long HJ 3rd, Nelimark RA, Podratz KC, Suman V, Keeney GL, Nikcevich DA, Kugler JW, Rowland KM Jr, Kardinal CG, Wos EJ. Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium. Gynecol Oncol. 2006 Mar; 100(3):501-5. Epub 2005 Sep 26.
    View PubMed
  116. Mariani A, Sebo TJ, Cliby WA, Keeney GL, Riehle DL, Lesnick TG, Podratz KC. Role of bcl-2 in endometrioid corpus cancer: an experimental study. Anticancer Res. 2006 Mar-Apr; 26 (2A):823-7
    View PubMed
  117. Magtibay PM, Salmon Z, Keeney GL, Podratz KC. Aggressive angiomyxoma of the female pelvis and perineum: a case series. Int J Gynecol Cancer. 2006 Jan-Feb; 16 (1):396-401
    View PubMed
  118. Kelemen LE, Sellers TA, Keeney GL, Lingle WL. Multivitamin and alcohol intake and folate receptor alpha expression in ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2005 Sep; 14: (9)2168-72.
    View PubMed
  119. Mariani A, Sebo TJ, Katzmann JA, Riehle DL, Dowdy SC, Keeney GL, Lesnick TG, Podratz KC. HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature. Anticancer Res. 2005 Jul-Aug; 25 (4):2921-7
    View PubMed
  120. Mariani A, Dowdy SC, Keeney GL, Haddock MG, Lesnick TG, Podratz KC. Predictors of vaginal relapse in stage I endometrial cancer. Gynecol Oncol. 2005 Jun; 97 (3):820-7
    View PubMed
  121. Mariani A, Sebo TJ, Katzmann JA, Roche PC, Keeney GL, Lesnick TG, Podratz KC. Endometrial cancer: can nodal status be predicted with curettage? Gynecol Oncol. 2005 Mar; 96 (3):594-600
    View PubMed
  122. Dowdy SC, Mariani A, Reinholz MM, Keeney GL, Spelsberg TC, Podratz KC, Janknecht R. Overexpression of the TGF-beta antagonist Smad7 in endometrial cancer. Gynecol Oncol. 2005 Feb; 96 (2):368-73
    View PubMed
  123. Mariani A, Dowdy SC, Keeney GL, Long HJ, Lesnick TG, Podratz KC. High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy. Gynecol Oncol. 2004 Oct; 95 (1):120-6
    View PubMed
  124. Mariani A, Keeney GL, Aletti G, Webb MJ, Haddock MG, Podratz KC. Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol. 2004 Mar; 92(3):833-8.
    View PubMed
  125. DiMarco DS, DiMarco CS, Zincke H, Webb MJ, Keeney GL, Bass S, Lightner DJ. Outcome of surgical treatment for primary malignant melanoma of the female urethra. J Urol. 2004 Feb; 171 (2 Pt 1):765-7
    View PubMed
  126. Gonzalez Bosquet J, Keeney GL, Mariani A, Webb MJ, Cliby WA. Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer. Gynecol Oncol. 2003 Dec; 91 (3):518-25
    View PubMed
  127. Dowdy SC, Constantinou CL, Hartmann LC, Keeney GL, Suman VJ, Hillman DW, Podratz KC. Long-term follow-up of women with ovarian cancer after positive second-look laparotomy. Gynecol Oncol. 2003 Dec; 91 (3):563-8
    View PubMed
  128. Giuntoli RL, Winburn KA, Silverman MB, Keeney GL, Cliby WA. Frozen section evaluation of cervical cold knife cone specimens is accurate in the diagnosis of microinvasive squamous cell carcinoma. Gynecol Oncol. 2003 Nov; 91(2):280-4.
    View PubMed
  129. Isotalo PA, Keeney GL, Sebo TJ, Riehle DL, Cheville JC. Adenomatoid tumor of the adrenal gland: a clinicopathologic study of five cases and review of the literature. Am J Surg Pathol. 2003 Jul; 27 (7):969-77
    View PubMed
  130. Giuntoli RL 2nd, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, Keeney GL, Gostout BS. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003 Jun; 89 (3):460-9
    View PubMed
  131. Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC. Endometrial cancer: predictors of peritoneal failure. Gynecol Oncol. 2003 May; 89 (2):236-42
    View PubMed
  132. Merideth MA, Cliby WA, Keeney GL, Lesnick TG, Nagorney DM, Podratz KC. Hepatic resection for metachronous metastases from ovarian carcinoma. Gynecol Oncol. 2003 Apr; 89 (1):16-21
    View PubMed
  133. Isotalo P, Keeney GL, Sebo TJ, Riehle D, Cheville JC. Adenomatoid tumor of the adernal gland. A clinicopathologic study of five cases and review of the literature Am J Surg Pathol. 2003; 27(7):969-77.
  134. Mariani A, Sebo TJ, Webb MJ, Riehle D, Katzmann JA, Keeney GL, Roche PC, Lesnick TG, Podratz KC. Molecular and histopathologic predictors of distant failure in endometrial cancer. Cancer Detect Prev. 2003; 27 (6):434-41
    View PubMed
  135. Mariani A, Webb MJ, Keeney GL, Lesnick TG, Podratz KC. Surgical stage I endometrial cancer: predictors of distant failure and death. Gynecol Oncol. 2002 Dec; 87 (3):274-80
    View PubMed
  136. Mariani A, Webb MJ, Keeney GL, Haddock MG, Aletti G, Podratz KC. Stage IIIC endometrioid corpus cancer includes distinct subgroups. Gynecol Oncol. 2002 Oct; 87 (1):112-7
    View PubMed
  137. Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol. 2002 Jul; 86 (1):38-44
    View PubMed
  138. Lae ME, Pereira PF, Keeney GL, Nascimento AG. Lipoblastoma-like tumour of the vulva: report of three cases of a distinctive mesenchymal neoplasm of adipocytic differentiation. Histopathology. 2002 Jun; 40 (6):505-9
    View PubMed
  139. Harewood GC, Wiersema LM, Halling AC, Keeney GL, Salamao DR, Wiersema MJ. Influence of EUS training and pathology interpretation on accuracy of EUS-guided fine needle aspiration of pancreatic masses. Gastrointest Endosc. 2002 May; 55 (6):669-73
    View PubMed
  140. Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC. Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol. 2002 Mar; 84(3):437-42.
    View PubMed
  141. Ryska A, Reynolds C, Keeney GL. Benign tumors of the breast with multinucleated stromal giant cells. Immunohistochemical analysis of six cases and review of the literature. Virchows Arch. 2001 Dec; 439(6):768-75.
    View PubMed
  142. Mariani A, Webb MJ, Keeney GL, Calori G, Podratz KC. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement. Gynecol Oncol. 2001 Oct; 83(1):72-80.
    View PubMed
  143. Clayton AC, Salomao DR, Keeney GL, Nascimento AG. Solitary fibrous tumor: a study of cytologic features of six cases diagnosed by fine-needle aspiration. Diagn Cytopathol. 2001 Sep; 25 (3):172-6
    View PubMed
  144. Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, Morrissey M, Calhoun E, Sen A, Kalli K, Keeney G, Roche P, Cliby W, Lu K, Schmandt R, Mills GB, Bast RC Jr, James CD, Couch FJ, Hartmann LC, Lillie J, Smith DI. Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res. 2001 Aug 1; 61(15):5895-904.
    View PubMed
  145. Dowdy SC, O'Kane DJ, Keeney GL, Boyd J, Podratz KC. Telomerase activity in sex cord-stromal tumors of the ovary. Gynecol Oncol. 2001 Aug; 82(2):257-60.
    View PubMed
  146. Mariani A, Webb MJ, Keeney GL, Podratz KC. Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Gynecol Oncol. 2001 Apr; 81(1):100-4.
    View PubMed
  147. McClure RF, Keeney GL, Sebo TJ, Cheville JC. Serous borderline tumor of the paratestis: a report of seven cases. Am J Surg Pathol. 2001 Mar; 25 (3):373-8
    View PubMed
  148. Giannini C, Scheithauer BW, Weaver AL, Burger PC, Kros JM, Mork S, Graeber MB, Bauserman S, Buckner JC, Burton J, Riepe R, Tazelaar HD, Nascimento AG, Crotty T, Crotty T, Keeney GL, Pernicone P, Altermatt H. Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol. 2001 Mar; 60 (3):248-62
    View PubMed
  149. Mariani A, Webb MJ, Keeney GL, Calori G, Podratz KC. Hematogenous dissemination in corpus cancer. Gynecol Oncol. 2001 Feb; 80 (2):233-8
    View PubMed
  150. Lee B, Cable DG, Keeney GL, van Heerden JA. Pseudomyxoma peritonei, with a case of mucinous adenocarcinoma of the appendix. Cont Surg. 2000 Dec; 56(12):742-44.
  151. Zanetta GM, Webb MJ, Li H, Keeney GL. Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol. 2000 Oct; 79(1):18-22.
    View PubMed
  152. Mariani A, Sebo TJ, Katzmann JA, Keeney GL, Roche PC, Lesnick TG, Podratz KC. Pretreatment assessment of prognostic indicators in endometrial cancer. Am J Obstet Gynecol. 2000 Jun; 182 (6):1535-44
    View PubMed
  153. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000 Jun; 182 (6):1506-19
    View PubMed
  154. Gebhart JB, Roche PC, Keeney GL, Lesnick TG, Podratz KC. Assessment of inhibin and p53 in granulosa cell tumors of the ovary. Gynecol Oncol. 2000 May; 77 (2):232-6
    View PubMed
  155. Silverman MB, Roche PC, Kho RM, Keeney GL, Li H, Podratz KC. Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma. Gynecol Oncol. 2000 Apr; 77(1):1-7.
    View PubMed
  156. Beard CM, Hartmann LC, Keeney GL, Crowson CS, Malkasian GD, O'Brien PC, Melton LJ 3rd, Melton LJ 3rd. Endometrial cancer in Olmsted County, MN: trends in incidence, risk factors and survival. Ann Epidemiol. 2000 Feb; 10 (2):97-105
    View PubMed
  157. Beard CM, Hartmann LC, Atkinson EJ, O'Brien PC, Malkasian GD, Keeney GL, Melton LJ 3rd, Melton LJ 3rd. The epidemiology of ovarian cancer: a population-based study in Olmsted County, Minnesota, 1935-1991. Ann Epidemiol. 2000 Jan; 10 (1):14-23
    View PubMed
  158. Magtibay PM, Perrone JF, Stanhope CR, Katzmann JA, Keeney GL, Li H. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix. Gynecol Oncol. 1999 Nov; 75(2):242-7.
    View PubMed
  159. Magtibay PM, Perrone JF, Stanhope CR, Katzmann JA, Keeney GL, Li H. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix. Gynecol Oncol. 1999 Oct; 75(1):20-4.
    View PubMed
  160. Murphy DP, Pantuck AJ, Amenta PS, Das KM, Cummings KB, Keeney GL, Weiss RE. Female urethral adenocarcinoma: immunohistochemical evidence of more than 1 tissue of origin. J Urol. 1999 Jun; 161(6):1881-4.
    View PubMed
  161. Reynolds C, Mick R, Donohue JH, Grant CS, Farley DR, Callans LS, Orel SG, Keeney GL, Lawton TJ, Czerniecki BJ. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol. 1999 Jun; 17 (6):1720-6
    View PubMed
  162. Kullo IJ, Oh JK, Keeney GL, Khandheria BK, Seward JB. Intracardiac leiomyomatosis: echocardiographic features. Chest. 1999 Feb; 115 (2):587-91
    View PubMed
  163. Frias AE Jr, Li H, Keeney GL, Podratz KC, Woodruff TK. Preoperative serum level of inhibin A is an independent prognostic factor for the survival of postmenopausal women with epithelial ovarian carcinoma. Cancer. 1999 Jan 15; 85 (2):465-71
    View PubMed
  164. Barrette BA, Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Podratz KC, Roche PC. Overexpression of p34cdc2 protein kinase in epithelial ovarian carcinoma. Mayo Clin Proc. 1997 Oct; 72(10):925-9.
    View PubMed
  165. Nascimento AG, Keeney GL, Sciot R, Fletcher CD. Polymorphous hemangioendothelioma: a report of two cases, one affecting extranodal soft tissues, and review of the literature. Am J Surg Pathol. 1997 Sep; 21 (9):1083-9
    View PubMed
  166. Yugueros P, Keeney GL, Bite U. Paget's disease of the groin: report of seven cases. Plast Reconstr Surg. 1997 Aug; 100 (2):336-9
    View PubMed
  167. Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Harmsen WS, Ziesmer SC, Roche PC, Podratz KC. Expression of nm23/nucleoside diphosphate kinase-A protein in endometrial carcinoma. Gynecol Oncol. 1997 Aug; 66(2):238-45.
    View PubMed
  168. Barrette B, Srivatsa P, Cliby W, Keeney G, Suman V, Podratz K, Roche P. Over-expression of p34(cdc2) protein kinase in epithelial ovarian carcinoma. Mayo Clin Proc. 1997; 72(10):925-929.
  169. Zanetta G, Keeney GL, Cha SS, Farr GH Jr, Katzmann JA, Wieand HS, Edmonson JH, Podratz KC. Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: its importance in long-term survival. Am J Obstet Gynecol. 1996 Nov; 175 (5):1217-25
    View PubMed
  170. Loy TS, Calaluce RD, Keeney GL. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol. 1996 Nov; 9(11):1040-4.
    View PubMed
  171. Hamel NW, Sebo TJ, Wilson TO, Keeney GL, Roche PC, Suman VJ, Hu TC, Podratz KC. Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma. Gynecol Oncol. 1996 Aug; 62(2):192-8.
    View PubMed
  172. Zanetta G, Keeney GL, Cha SS, Wieand HS, Katzmann JA, Podratz KC. DNA index by flow cytometric analysis: an additional prognostic factor in advanced ovarian carcinoma without residual disease after primary operation. Gynecol Oncol. 1996 Aug; 62(2):208-12.
    View PubMed
  173. Davis KP, Hartmann LK, Keeney GL, Shapiro H. Primary ovarian carcinoid tumors. Gynecol Oncol. 1996 May; 61(2):259-65.
    View PubMed
  174. Srivatsa PJ, Cliby WA, Keeney GL, Dodson MK, Suman VJ, Roche PC, Podratz KC. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma. Gynecol Oncol. 1996 Mar; 60(3):363-72.
    View PubMed
  175. Zanetta GM, Keeney GL, Kimlinger TK, Katzmann JA, Podratz KC. Concordance of DNA ploidy pattern as measured by flow cytometry in primary, metastatic, and persistent ovarian carcinoma. Gynecol Oncol. 1996 Feb; 60(2):213-6.
    View PubMed
  176. Dodson MK, Cliby WA, Pettavel PP, Keeney GL, Podratz KC. Female urethral adenocarcinoma: evidence for more than one tissue of origin? Gynecol Oncol. 1995 Dec; 59(3):352-7.
    View PubMed
  177. Lacy MQ, Hartmann LC, Keeney GL, Cha SC, Wieand HS, Podratz KC, Roche PC. c-erbB-2 and p53 expression in fallopian tube carcinoma. Cancer. 1995 Jun 15; 75 (12):2891-6
    View PubMed
  178. Persons DL, Hartmann LC, Herath JF, Keeney GL, Jenkins RB. Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors. Am J Clin Pathol. 1994 Dec; 102 (6):775-9
    View PubMed
  179. Dodson MK, Cliby WA, Keeney GL, Peterson MF, Podratz KC. Skene's gland adenocarcinoma with increased serum level of prostate-specific antigen. Gynecol Oncol. 1994 Nov; 55 (2):304-7
    View PubMed
  180. Srivatsa PJ, Keeney GL, Podratz KC. Disseminated cervical adenoma malignum and bilateral ovarian sex cord tumors with annular tubules associated with Peutz-Jeghers syndrome. Gynecol Oncol. 1994 May; 53 (2):256-64
    View PubMed
  181. Nascimento AG, Keeney GL, Fletcher CD. Deciduoid peritoneal mesothelioma. An unusual phenotype affecting young females. Am J Surg Pathol. 1994 May; 18(5):439-45.
    View PubMed
  182. Dodson MK, Cliby WA, Xu HJ, DeLacey KA, Hu SX, Keeney GL, Li J, Podratz KC, Jenkins RB, Benedict WF. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus. Cancer Res. 1994 Feb 1; 54(3):610-3.
    View PubMed
  183. Hartmann LC, Podratz KC, Keeney GL, Kamel NA, Edmonson JH, Grill JP, Su JQ, Katzmann JA, Roche PC. Prognostic significance of p53 immunostaining in epithelial ovarian cancer. J Clin Oncol. 1994 Jan; 12 (1):64-9
    View PubMed
  184. Rizkalla K, Ahmad D, Garcia B, Hutton L, Novick R, Keeney GL. Primary malignant fibrous histiocytoma of the pluera. A case report and review of the literature. Respiratory Medicine. 1994; 88(9):711-4.
    View PubMed
  185. Jenkins RB, Bartelt D Jr, Stalboerger P, Persons D, Dahl RJ, Podratz K, Keeney G, Podratz K, Keeney G, Hartmann L, Hartmann L. Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet. 1993 Nov; 71 (1):76-86
    View PubMed
  186. Dodson MK, Hartmann LC, Cliby WA, DeLacey KA, Keeney GL, Ritland SR, Su JQ, Podratz KC, Jenkins RB. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Cancer Res. 1993 Oct 1; 53(19):4456-60.
    View PubMed
  187. Cliby W, Ritland S, Hartmann L, Dodson M, Halling KC, Keeney G, Podratz KC, Jenkins RB. Human epithelial ovarian cancer allelotype. Cancer Res. 1993 May 15; 53 (10 Suppl):2393-8
    View PubMed
  188. Leiserowitz GS, Harris SA, Subramaniam M, Keeney GL, Podratz KC, Spelsberg TC. The proto-oncogene c-fms is overexpressed in endometrial cancer. Gynecol Oncol. 1993 May; 49 (2):190-6
    View PubMed
  189. Persons DL, Hartmann LC, Herath JF, Borell TJ, Cliby WA, Keeney GL, Jenkins RB. Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas. Am J Pathol. 1993 Mar; 142 (3):733-41
    View PubMed
  190. Hetzel DJ, Wilson TO, Keeney GL, Roche PC, Cha SS, Podratz KC. HER-2/neu expression: a major prognostic factor in endometrial cancer. Gynecol Oncol. 1992 Nov; 47 (2):179-85
    View PubMed
  191. Hartmann LC, Sebo TJ, Kamel NA, Podratz KC, Cha SS, Wieand HS, Keeney GL, Roche PC. Proliferating cell nuclear antigen in epithelial ovarian cancer: relation to results at second-look laparotomy and survival. Gynecol Oncol. 1992 Nov; 47 (2):191-5
    View PubMed
  192. Zanetta GM, Katzmann JA, Keeney GL, Kinney WK, Cha SS, Podratz KC. Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma. Gynecol Oncol. 1992 Jul; 46 (1):13-9
    View PubMed
  193. Kerley SW, Blute ML, Keeney GL. Multifocal malignant melanoma arising in vesicovaginal melanosis. Archives of Pathology & Laboratory Medicine. 1991 Sep; 115(9):950-2.
    View PubMed
  194. Igel TC, Engen DE, Banks PM, Keeney GL. Renal plasmacytoma: Mayo Clinic experience and review of the literature. Urology. 1991 Apr; 37 (4):385-9
    View PubMed
  195. Ransom DT, Patel SR, Keeney GL, Malkasian GD, Edmonson JH. Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy. Cancer. 1990 Sep 15; 66 (6):1091-4
    View PubMed
  196. Keeney GL, Unni KK, Beabout JW, Pritchard DJ. Adamantinoma of long bones. A clinicopathologic study of 85 cases. Cancer. 1989 Aug 1; 64 (3):730-7
    View PubMed
  197. Keeney GL, Banks PM, Linscheid RL. Subungual keratoacanthoma. Report of a case and review of the literature. Arch Dermatol. 1988 Jul; 124(7):1074-6.
    View PubMed
  198. Keeney GL, Thrasher TV.. Metaplastic papillary tumor of the fallopian tube: a case reprot with ultrastructure. International Journal of Gynecological Pathology. 1988; 7(1):86-92.
    View PubMed
  199. Keeney G, Unni KK, Beabout JW, Pritchard DJ. Adamantinoma of long bones: a study of 84 cases. Lab Invest. 1987 Jan; 56:36A.
  200. Young TW, Keeney GL, Bull BS. Red cell fragmentation in human disease (a light and scanning electron microscope study). Blood Cells. 1984; 10(2-3):493-501.
    View PubMed